HomeNewsBusinessMarketsHow coronavirus could impact Indian economy, financial markets

How coronavirus could impact Indian economy, financial markets

We expect the broad 70.70-72.50 range to hold. We expect the RBI to smoothen volatility intraday. A panic move is likely only on a break as well as a close above Rs 72.50 per USD.

February 24, 2020 / 11:33 IST
Story continues below Advertisement
Abhishek Goenka
Abhishek Goenka

Abhishek Goenka

While coronavirus may not have impacted the country directly as much, but the Indian economy, which is just about showing some signs of recovery, may not escape unscathed. The green shoots could get nipped in the bud.

Story continues below Advertisement

India's annual trade with China is ~$90 billion--India imports goods worth $75 billion and exports goods worth $15 billion. On account of factory closures in China, supply chains would get disrupted and this could result in shortages, especially of electronic goods and medicines.

A lot of pharma companies rely on APIs (active pharmaceutical ingredients) sourced from parts of China that are worst affected by the virus outbreak. We may see a temporary contraction in imports till the time some semblance of normalcy is restored in China.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show